ALPS Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-27,512
Closed -$1.51M 818
2019
Q3
$1.51M Sell
27,512
-2,223
-7% -$114K 0.01% 242
2019
Q2
$1.21M Buy
+29,735
New +$1.08M 0.01% 289
2018
Q1
Sell
-8,398
Closed -$453K 871
2017
Q4
$453K Hold
8,398
﹤0.01% 639
2017
Q3
$487K Buy
+8,398
New +$439K ﹤0.01% 572
2017
Q1
Sell
-8,849
Closed -$433K 737
2016
Q4
$433K Sell
8,849
-116
-1% -$5.36K ﹤0.01% 532
2016
Q3
$429K Buy
+8,965
New +$443K ﹤0.01% 414
2016
Q1
Sell
-14,012
Closed -$535K 639
2015
Q4
$535K Hold
14,012
0.01% 361
2015
Q3
$4.46K Buy
14,012
+778
+6% +$27.1K ﹤0.01% 591
2015
Q2
$437K Buy
13,234
+206
+2% +$7.35K ﹤0.01% 609
2015
Q1
$536K Buy
13,028
+404
+3% +$16.3K ﹤0.01% 352
2014
Q4
$514K Sell
12,624
-1,792
-12% -$70K ﹤0.01% 448
2014
Q3
$528K Buy
14,416
+580
+4% +$25.1K ﹤0.01% 551
2014
Q2
$641K Buy
13,836
+352
+3% +$15.7K 0.01% 294
2014
Q1
$554K Sell
13,484
-6,922
-34% -$257K 0.01% 493
2013
Q4
$679K Buy
20,406
+9,878
+94% +$305K 0.01% 161
2013
Q3
$252K Buy
+10,528
New +$236K ﹤0.01% 377

Other funds holding ANIK